Siemens collaborates with CDC to develop a novel process for standardizing SARS-CoV-2 assays
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
New assay is designed to help laboratories address greater demand for opioid testing
The Atellica Solution from Siemens Healthineers promises more control and increased simplicity in your lab workflows
The Siemens Healthineers High-Sensitivity Troponin I assays can detect lower levels of troponin compared to conventional assays
World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance
Discover the Scientists' Choice Award nominee Atellica Solution at AACC July 29 - August 2, 2018
Siemens becomes a preferred supplier for automation solutions
Testing at the point-of-care improves patient care with results in less than a minute
FTD's broad range of CE-marked infectious disease detection tests and syndromic panels expands the Siemens Healthineers molecular diagnostics portfolio
Proven nephelometric technology provides high precision, reproducibility, and antigen-excess security for confident clinical decisions
Revolutionary new chemistry analyzers said to offer flexibility, simplified workflow and tighter control gain CE Mark
The new MR scanner provides an enhanced level of detail for musculoskeletal and neurological applications, giving clinicians improved diagnostic capabilities